Citation Impact
Citing Papers
Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection
2008
Interstitial Lung Disease in Inflammatory Myopathies: Clinical Phenotypes and Prognosis
2013
Phenotypic Characterization of Autoreactive B Cells—Checkpoints of B Cell Tolerance in Patients with Systemic Lupus Erythematosus
2009
A natural human monoclonal antibody targeting Staphylococcus Protein A protects against Staphylococcus aureus bacteremia
2018
Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization
2012
Memory B and memory plasma cells
2010
Antibiotic resistance: a rundown of a global crisis
2018 Standout
Approval of Raxibacumab for the Treatment of Inhalation Anthrax Under the US Food and Drug Administration “Animal Rule”
2015
Encoded libraries of chemically modified peptides
2015 StandoutNobel
Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases
2008
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
2011 StandoutNobel
The non-canonical NF-κB pathway in immunity and inflammation
2017
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Targeting BAFF in autoimmunity
2010
Systemic Lupus Erythematosus
2011 Standout
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
2011
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
2011
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
Activation-Induced Cytidine Deaminase Expression in CD4+ T Cells is Associated with a Unique IL-10-Producing Subset that Increases with Age
2011 StandoutNobel
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
2013 Standout
Alkaloids: An overview of their antibacterial, antibiotic-enhancing and antivirulence activities
2014 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Computational design of orthogonal nucleoside kinases
2010 StandoutNobel
Belimumab: Review of Use in Systemic Lupus Erythematosus
2012
Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis
2018
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases
2011
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
The Bcl-2 Family Antagonist ABT-737 Significantly Inhibits Multiple Animal Models of Autoimmunity
2009
Inflammatory Muscle Diseases
2015 Standout
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
2009
Drugs derived from phage display
2013
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Targeting virulence not viability in the search for future antibacterials
2014
Belimumab
2011
Experimental and Clinical Pharmacology ofAndrographis paniculataand Its Major Bioactive Phytoconstituent Andrographolide
2013 Standout
Obiltoxaximab: Adding to the Treatment Arsenal for Bacillus anthracis Infection
2017
Phage and Yeast Display
2015
The role of Fc–FcγR interactions in IgG-mediated microbial neutralization
2015
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Phage display-derived human antibodies in clinical development and therapy
2016
Works of John Zhong being referenced
A Phase 1 Study of PAmAb, a Fully Human Monoclonal Antibody against Bacillus anthracis Protective Antigen, in Healthy Volunteers
2005
Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
2008
Raxibacumab for the Treatment of Inhalational Anthrax
2009
Safety, Pharmacokinetics, and Antiviral Activity of HGS004, a Novel Fully Human IgG4 Monoclonal Antibody against CCR5, in HIV‐1–Infected Patients
2008
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus
2008
Chronic Administration of Belimumab, a BLyS Antagonist, Decreases Tissue and Peripheral Blood B-Lymphocyte Populations in Cynomolgus Monkeys: Pharmacokinetic, Pharmacodynamic, and Toxicologic Effects
2006
Added Benefit of Raxibacumab to Antibiotic Treatment of Inhalational Anthrax
2014